BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 28815810)

  • 1. Proteome characterization of human pancreatic cyst fluid from intraductal papillary mucinous neoplasm by liquid chromatography/tandem mass spectrometry.
    Park J; Han D; Do M; Woo J; Wang JI; Han Y; Kwon W; Kim SW; Jang JY; Kim Y
    Rapid Commun Mass Spectrom; 2017 Oct; 31(20):1761-1772. PubMed ID: 28815810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyst fluid carcinoembryonic antigen level is not predictive of invasive cancer in patients with intraductal papillary mucinous neoplasm of the pancreas.
    Kucera S; Centeno BA; Springett G; Malafa MP; Chen YA; Weber J; Klapman J
    JOP; 2012 Jul; 13(4):409-13. PubMed ID: 22797397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synchronous pancreatic solid pseudopapillary neoplasm and intraductal papillary mucinous neoplasm.
    Hirabayashi K; Zamboni G; Ito H; Ogawa M; Kawaguchi Y; Yamashita T; Nakagohri T; Nakamura N
    World J Gastroenterol; 2013 Jun; 19(21):3358-63. PubMed ID: 23745041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyst fluid carcinoembryonic antigen is an accurate diagnostic marker of pancreatic mucinous cysts.
    Cizginer S; Turner BG; Bilge AR; Karaca C; Pitman MB; Brugge WR
    Pancreas; 2011 Oct; 40(7):1024-8. PubMed ID: 21775920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraductal tubulopapillary neoplasm of the pancreas on fine needle aspiration: case report with differential diagnosis.
    Guan H; Gurda G; Lennon AM; Hruban RH; Erozan YS
    Diagn Cytopathol; 2014 Feb; 42(2):156-60. PubMed ID: 22807417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross Validation of the Monoclonal Antibody Das-1 in Identification of High-Risk Mucinous Pancreatic Cystic Lesions.
    Das KK; Geng X; Brown JW; Morales-Oyarvide V; Huynh T; Pergolini I; Pitman MB; Ferrone C; Al Efishat M; Haviland D; Thompson E; Wolfgang C; Lennon AM; Allen P; Lillemoe KD; Fields RC; Hawkins WG; Liu J; Castillo CF; Das KM; Mino-Kenudson M
    Gastroenterology; 2019 Sep; 157(3):720-730.e2. PubMed ID: 31175863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of next-generation sequencing on the clinical diagnosis of pancreatic cysts.
    Jones M; Zheng Z; Wang J; Dudley J; Albanese E; Kadayifci A; Dias-Santagata D; Le L; Brugge WR; Fernandez-del Castillo C; Mino-Kenudson M; Iafrate AJ; Pitman MB
    Gastrointest Endosc; 2016 Jan; 83(1):140-8. PubMed ID: 26253016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic cyst fluid protein expression profiling for discriminating between serous cystadenoma and intraductal papillary mucinous neoplasm.
    Allen PJ; Qin LX; Tang L; Klimstra D; Brennan MF; Lokshin A
    Ann Surg; 2009 Nov; 250(5):754-60. PubMed ID: 19806054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The level of carcinoembryonic antigen and the presence of mucin as predictors of cystic pancreatic mucinous neoplasia.
    Shami VM; Sundaram V; Stelow EB; Conaway M; Moskaluk CA; White GE; Adams RB; Yeaton P; Kahaleh M
    Pancreas; 2007 May; 34(4):466-9. PubMed ID: 17446847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyst fluid analysis obtained by EUS-guided FNA in the evaluation of discrete cystic neoplasms of the pancreas: a prospective single-center experience.
    Linder JD; Geenen JE; Catalano MF
    Gastrointest Endosc; 2006 Nov; 64(5):697-702. PubMed ID: 17055859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic mucin profiling for the identification of cystic precursors of pancreatic cancer.
    Jabbar KS; Verbeke C; Hyltander AG; Sjövall H; Hansson GC; Sadik R
    J Natl Cancer Inst; 2014 Feb; 106(2):djt439. PubMed ID: 24523528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmembrane mucin MUC13 distinguishes intraductal papillary mucinous neoplasms from non-mucinous cysts and is associated with high-risk lesions.
    Stiles ZE; Khan S; Patton KT; Jaggi M; Behrman SW; Chauhan SC
    HPB (Oxford); 2019 Jan; 21(1):87-95. PubMed ID: 30115565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis index CD105 (endoglin)/CD31 (PECAM-1) as a predictive factor for invasion and proliferation in intraductal papillary mucinous neoplasm (IPMN) of the pancreas.
    Tachezy M; Reichelt U; Melenberg T; Gebauer F; Izbicki JR; Kaifi JT
    Histol Histopathol; 2010 Oct; 25(10):1239-46. PubMed ID: 20712008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study.
    Khalid A; Zahid M; Finkelstein SD; LeBlanc JK; Kaushik N; Ahmad N; Brugge WR; Edmundowicz SA; Hawes RH; McGrath KM
    Gastrointest Endosc; 2009 May; 69(6):1095-102. PubMed ID: 19152896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of proteomics to differentiate between benign and potentially malignant pancreatic cysts.
    Cuoghi A; Farina A; Z'graggen K; Dumonceau JM; Tomasi A; Hochstrasser DF; Genevay M; Lescuyer P; Frossard JL
    J Proteome Res; 2011 May; 10(5):2664-70. PubMed ID: 21425880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyst Fluid Analysis in Pancreatic Intraductal Papillary Mucinous Neoplasms.
    Allen PJ; Iacobuzio-Donahue CA; Klimstra DS
    Clin Cancer Res; 2016 Oct; 22(20):4966-4967. PubMed ID: 27573170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of carcinoembryonic antigen and molecular analysis in pancreatic cyst fluid.
    Sawhney MS; Devarajan S; O'Farrel P; Cury MS; Kundu R; Vollmer CM; Brown A; Chuttani R; Pleskow DK
    Gastrointest Endosc; 2009 May; 69(6):1106-10. PubMed ID: 19249035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Very high CEA level in a large pancreatic cyst: is it a surgical indication by itself?
    Zanini N; Fornelli A; Fiscaletti M; Fabbri C; Lombardi R; Polifemo AM; Baccarini P; Masetti M; Jovine E
    Pancreatology; 2012; 12(3):203-5. PubMed ID: 22687373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyst fluid SPINK1 may help to differentiate benign and potentially malignant cystic pancreatic lesions.
    Räty S; Sand J; Laukkarinen J; Vasama K; Bassi C; Salvia R; Nordback I
    Pancreatology; 2013; 13(5):530-3. PubMed ID: 24075519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly Accurate Identification of Cystic Precursor Lesions of Pancreatic Cancer Through Targeted Mass Spectrometry: A Phase IIc Diagnostic Study.
    Jabbar KS; Arike L; Verbeke CS; Sadik R; Hansson GC
    J Clin Oncol; 2018 Feb; 36(4):367-375. PubMed ID: 29166170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.